Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
9.68
0.25
2.58%
Share Warrants & Outstandings
Total Reserve
-24.79
0.52
-25.31
-4,867.31%
Shareholder's Funds
-14.87
10.20
-25.07
-245.78%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.53
0.75
17.78
2,370.67%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.53
0.75
17.78
2,370.67%
Deferred Tax Assets / Liabilities
-0.90
-0.01
-0.89
-8,900.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
17.62
0.74
16.88
2,281.08%
Current Liabilities
Trade Payables
2.57
0.96
1.61
167.71%
Other Current Liabilities
1.79
0.14
1.65
1,178.57%
Short Term Borrowings
3.05
0.00
3.05
0.00%
Short Term Provisions
2.74
0.00
2.74
0.00%
Total Current Liabilities
10.15
1.10
9.05
822.73%
Total Liabilities
12.91
12.04
0.87
7.23%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.76
0.11
27.65
25,136.36%
Less: Accumulated Depreciation
22.49
0.06
22.43
37,383.33%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.27
0.04
5.23
13,075.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
0.52
-0.51
-98.08%
Long Term Loans & Advances
1.29
0.00
1.29
0.00%
Other Non Current Assets
0.00
0.62
-0.62
-100.00%
Total Non-Current Assets
6.57
1.18
5.39
456.78%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.13
0.08
4.05
5,062.50%
Sundry Debtors
1.41
3.74
-2.33
-62.30%
Cash and Bank
0.04
0.03
0.01
33.33%
Other Current Assets
0.74
0.00
0.74
0.00%
Short Term Loans and Advances
0.02
7.00
-6.98
-99.71%
Total Current Assets
6.34
10.85
-4.51
-41.57%
Net Current Assets (Including Current Investments)
-3.81
9.76
-13.57
-139.04%
Total Current Assets Excluding Current Investments
6.34
10.85
-4.51
-41.57%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
12.91
12.04
0.87
7.23%
Contingent Liabilities
1.33
0.00
1.33
0.00%
Total Debt
21.58
0.75
20.83
2,777.33%
Book Value per share (adjusted)
-14.98
10.54
-25.52
-242.13%
Annual - Borrowings
Borrowings 21.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 6.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024






